Jacek Sygut: Influence Statistics

Jacek Sygut

Jacek Sygut

Department of Tumor Pathology, Greater Poland Cancer Centre in Poznan, Poznan. | Holycross Cancer Centre Department of Surgical Pathology Kielce Poland | Holycross Cancer ...

Jacek Sygut: Expert Impact

Concepts for which Jacek Sygut has direct influence: Aggressive fibromatosis , Desmoid tumor , Thyroid cancer , Thyroid carcinoma , Follicular thyroid , Papillary thyroid carcinoma , Papillary carcinoma .

Jacek Sygut: KOL impact

Concepts related to the work of other authors for which for which Jacek Sygut has influence: Thyroid cancer , Brafv600e mutation , Desmoid tumors , Malignant melanoma , Aggressive fibromatosis , Rhabdomyoblastic differentiation , Becker nevus .

KOL Resume for Jacek Sygut

Year
2017

Department of Tumor Pathology, Greater Poland Cancer Centre in Poznan, Poznan.

2014

Holycross Cancer Centre Department of Surgical Pathology Kielce Poland

2013

Holycross Cancer Centre in Kielce, Poland

2009

Department of Neoplasm Pathology, Świętokrzyski Centre of Oncology, Kielce, Poland

2007

Zakład Patologii Nowotworów Świętokrzyskiego Centrum Onkologii w Kielcach

2004

Świętokrzyskie Centrum Onkologii, ul. Artwińskiego 3, 25-734 Kielce

Prominent publications by Jacek Sygut

KOL-Index: 10049 . CONTEXT: An activating mutation in the gene BRAF has been correlated with poorer prognosis and more aggressive clinical course in papillary thyroid carcinoma (PTC). We therefore hypothesized that the good prognosis, high 5-year disease-free rate and high survival rate of patients with less aggressive papillary thyroid microcarcinoma (pT1aNo-x) would be associated with a lower incidence of ...
Known for Brafv600e Mutation | Papillary Thyroid | Ptc Study | Lymph Node
KOL-Index: 8148 . BACKGROUND: Phaeochromocytoma (PCC) and paraganglioma (PGL) can occur sporadically or as a part of familial cancer syndromes. Red flags of hereditary syndromes are young age and multifocal tumours. We hypothesized that such patients are candidates for further molecular diagnosis in case of normal results in 'classical' genes. MATERIAL AND METHODS: We selected patients with PCC/PGL under ...
Known for Hereditary Syndromes | Mutations Max | Neoplasms Adult | Pcc Pgl
KOL-Index: 4868 . The aims of this study were to analyze the cadherin/catenin adhesion complex in cells from abdominal and extra-abdominal aggressive fibromatosis tumors, and to estimate the correlation between the expression of the tested proteins and the clinical data of the desmoid patients. Immunohistochemistry was used to examine the expression of the cadherin/catenin adhesion complex: APC protein, ...
Known for Aggressive Fibromatosis | Desmoid Tumor | Beta Catenin | Positive Cells
KOL-Index: 2463 . Tuberous sclerosis complex (tsc), a phacomatosis, is a rare genetic disease (autosomal dominant; incidence: 1 in 6,800-17,300) associated with mutations in the TSC1 and TSC2 genes, 70% of which are sporadic. The disease causes benign tumours in the brain, kidneys, heart, lungs, skin, and eyes; thyroid lesions are extremely rare. A 13-year-old euthyroid boy with a hereditary form of tsc ...
Known for Papillary Thyroid Carcinoma | Tuberous Sclerosis | Tsc1 Tsc2 Genes | Tsc Rare

Key People For Aggressive Fibromatosis

Top KOLs in the world
#1
Benjamin Aaron Alman
aggressive fibromatosis desmoid tumors fracture repair
#2
Murray, F Brennan
gastric cancer soft tissue pancreatic adenocarcinoma
#3
Alessandro Gronchi
retroperitoneal sarcoma soft tissue neoadjuvant chemotherapy
#4
Hubert J Wolfe
situ hybridization aggressive fibromatosis primary biliary cirrhosis
#5
Gunar K Zagars
radiation therapy prostate cancer androgen ablation
#6
Jyrki J REITAMO
desmoid tumor ulcerative colitis intramuscular myxoma

Department of Tumor Pathology, Greater Poland Cancer Centre in Poznan, Poznan. | Holycross Cancer Centre Department of Surgical Pathology Kielce Poland | Holycross Cancer Centre in Kielce, Poland | Holycross Cancer Center Department of Pathology and